Corneal macrophage infiltrates following ocular herpes simplex virus type 1 challenge vary in BALB/c mice vaccinated with different vaccines

By Ghiasi H.   Hofman F.M.   Wallner K.   Cai S.   Perng G.-C.   Nesburn A.B.   Wechsler S.L.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1266-1273

Elsevier

Access to resources Recommend Favorite

DNA immunization utilizing a herpes simplex virus type 2 myogenic DNA vaccine protects mice from mortality and prevents genital herpes

By Gebhard J.R.J.R.   Zhu J.   Cao X.   Minnick J.   Araneo A.B.A.  

Vaccine, Vol. 18, Iss. 17, 2000-03 ,pp. : 1837-1846

Elsevier

Access to resources Recommend Favorite

Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection

By Bernstein D.I.   Tepe E.R.   Mester J.C.   Arnold R.L.   Stanberry L.R.   Higgins T.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1964-1969

Elsevier

Access to resources Recommend Favorite

Immunity induced by DNA immunization with herpes simplex virus type 2 glycoproteins B and C

By Mester J.C.   Twomey T.A.   Tepe E.T.   Bernstein D.I.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 875-883

Elsevier

Access to resources Recommend Favorite

Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands

By Eo S.K.   Lee S.   Kumaraguru U.   Rouse B.T.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4685-4693

Elsevier

Access to resources Recommend Favorite